Drug Trial News

RSS
FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T

FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T

Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant

Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant

WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine

WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine

First-of-its-kind study to test a personalized vaccine in cancer patient

First-of-its-kind study to test a personalized vaccine in cancer patient

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Arcus Biosciences announces presentation of final results from Phase 1 study of AB928 at ESMO 2018

Arcus Biosciences announces presentation of final results from Phase 1 study of AB928 at ESMO 2018

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

Lyra Therapeutics announces presentation of Phase 1 clinical data for LYR-210 in CRS patients

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

T-CALM Phase 2 clinical study results offer hope for essential tremor patients

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Lilly, Boehringer Ingelheim present full results of cardiovascular outcome trial, CARMELINA

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

RCIGM and IDbyDNA launch clinical trial to improve diagnostics for pediatric CNS infections

RCIGM and IDbyDNA launch clinical trial to improve diagnostics for pediatric CNS infections

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Genentech announces clinical data from studies investigating risdiplam in spinal muscular atrophy

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Human clinical trial of investigational calcification inhibitor generates promising results

Human clinical trial of investigational calcification inhibitor generates promising results

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Cancer drug trials focus on progression-free survival and overlook health-related quality of life

Cancer drug trials focus on progression-free survival and overlook health-related quality of life